>>Signaling Pathways>> Antibody-drug Conjugate/ADC Related>> ADC Linker>>SPDP (SPDP Crosslinker)

SPDP (SPDP Crosslinker)

Catalog No.GC30018

SPDP(SPDP 가교제)(SPDP(SPDP 가교제) 가교제)는 NHS-에스테르 및 피리딜디티올 반응성 기를 통한 아민-설프히드릴 접합을 위한 단쇄 가교제로서 시스테인 설프하이드릴과 절단 가능한(환원 가능한) 이황화 결합을 형성합니다. 항체-약물 접합체(ADC)에 사용되는 글루타티온 절단 가능한 ADC 링커입니다.

Products are for research use only. Not for human use. We do not sell to patients.

SPDP (SPDP Crosslinker) Chemical Structure

Cas No.: 68181-17-9

Size 가격 재고 수량
10mg
US$39.00
재고 있음
50mg
US$105.00
재고 있음
100mg
US$175.00
재고 있음
200mg
US$252.00
재고 있음
500mg
US$525.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

SPDP is a short-chain crosslinker for amine-to-sulfhydryl conjugation via NHS-ester and pyridyldithiol reactive groups that form cleavable (reducible) disulfide bonds with cysteine sulfhydryls. equal amounts of anti-CD11c and anti-CTLA-4 Abs (in borate buffered saline; pH 8.5) were activated using SPDP .

[1]. Lobedanz S et al. A periplasmic coiled-coil interface underlying TolC recruitment and the assembly of bacterial drug effluxpumps. Proc Natl Acad Sci U S A, 2007 Mar 13, 104(11):4612-7. [2]. Karumuthil-Melethil S et al. Dendritic cell-directed CTLA-4 engagement during pancreatic beta cell antigen presentation delays type 1diabetes. J Immunol 2010 Jun 15, 184(12):6695-708.

리뷰

Review for SPDP (SPDP Crosslinker)

Average Rating: 5 ★★★★★ (Based on Reviews and 39 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for SPDP (SPDP Crosslinker)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.